TJP1 and cancer: Increasing CCL22 levels increased the CCR4-expressing cancer cell migration rate, as well as vimentin, snail, slug, and β-catenin expression levels, in contrast, ZO-1 expression was decreased, suggesting that CCL22 combined with its receptor CCR4 could remodel the EMT process and promote the migration in CC cells.